The Role of Endoscopic Ultrasound in the Detection of Pancreatic Lesions in High-risk Individuals

Overview

Journal Fam Cancer

Publisher Springer

Specialty Oncology

Date 2024 Apr 4

PMID 38573399

Authors

Kasper A Overbeek

Djuna L Cahen

Marco J Bruno

Affiliations

Soon will be listed here.

Abstract

Individuals at high risk of developing pancreatic ductal adenocarcinoma are eligible for surveillance within research programs. These programs employ periodic imaging in the form of magnetic resonance imaging/magnetic resonance cholangiopancreatography or endoscopic ultrasound for the detection of early cancer or high-grade precursor lesions. This narrative review discusses the role of endoscopic ultrasound within these surveillance programs. It details its overall strengths and limitations, yield, burden on patients, and how it compares to magnetic resonance imaging. Finally, recommendations are given when and how to incorporate endoscopic ultrasound in the surveillance of high-risk individuals.

Citing Articles

Comparison of sedation with pentazocine or pethidine hydrochloride for endoscopic ultrasonography in outpatients: A single-center retrospective study.

Urabe M, Ikezawa K, Seiki Y, Watsuji K, Kawamoto Y, Hirao T DEN Open. 2025; 5(1):e70048.

PMID: 39741901 PMC: 11687558. DOI: 10.1002/deo2.70048.

MSI-H Detection by ddPCR in Endoscopic Ultrasound Fine Needle Biopsy (EUS-FNB) from Pancreatic Ductal Adenocarcinoma.

Piano M, Boldrin E, Moserle L, Salerno N, Fanelli D, Peserico G Int J Mol Sci. 2024; 25(20).

PMID: 39456871 PMC: 11507452. DOI: 10.3390/ijms252011090.

Twenty-five years of surveillance for familial and hereditary pancreatic ductal adenocarcinoma: Historical perspectives and introduction to the special issue.

Vasen H, Canto M, Goggins M Fam Cancer. 2024; 23(3):209-215.

PMID: 38844715 PMC: 11255030. DOI: 10.1007/s10689-024-00404-0.

References

Hruban R, Canto M, Goggins M, Schulick R, Klein A . Update on familial pancreatic cancer. Adv Surg. 2010; 44:293-311. PMC: 2966038. DOI: 10.1016/j.yasu.2010.05.011. View

Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, MacGregor-Das A . Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. J Clin Oncol. 2017; 35(30):3382-3390. PMC: 5648172. DOI: 10.1200/JCO.2017.72.3502. View

Canto M, Hruban R, Fishman E, Kamel I, Schulick R, Zhang Z . Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012; 142(4):796-804. PMC: 3321068. DOI: 10.1053/j.gastro.2012.01.005. View

Bipat S, Phoa S, van Delden O, Bossuyt P, Gouma D, Lameris J . Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr. 2005; 29(4):438-45. DOI: 10.1097/01.rct.0000164513.23407.b3. View

Nawaz H, Fan C, Kloke J, Khalid A, McGrath K, Landsittel D . Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis. JOP. 2013; 14(5):484-97. PMC: 4407641. DOI: 10.6092/1590-8577/1512. View

Tamburrino D, Riviere D, Yaghoobi M, Davidson B, Gurusamy K . Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev. 2016; 9:CD011515. PMC: 6457597. DOI: 10.1002/14651858.CD011515.pub2. View

Rahman M, Chan B, Far P, Mbuagbaw L, Thabane L, Yaghoobi M . Endoscopic ultrasound versus computed tomography in determining the resectability of pancreatic cancer: A diagnostic test accuracy meta-analysis. Saudi J Gastroenterol. 2020; 26(3):113-119. PMC: 7392294. DOI: 10.4103/sjg.SJG_39_20. View

Rijkers A, Valkema R, Duivenvoorden H, van Eijck C . Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol. 2014; 40(7):794-804. DOI: 10.1016/j.ejso.2014.03.016. View

Aslanian H, Lee J, Canto M . AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterology. 2020; 159(1):358-362. DOI: 10.1053/j.gastro.2020.03.088. View

Santhosh S, Mittal B, Bhasin D, Srinivasan R, Rana S, Das A . Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. J Gastroenterol Hepatol. 2013; 28(2):255-61. DOI: 10.1111/jgh.12068. View

10.

Seo S, Doi R, Machimoto T, Kami K, Masui T, Hatano E . Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg. 2008; 15(6):634-9. DOI: 10.1007/s00534-007-1339-x. View

11.

Matsumoto I, Shirakawa S, Shinzeki M, Asari S, Goto T, Ajiki T . 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2013; 11(6):712-8. DOI: 10.1016/j.cgh.2012.12.033. View

12.

Brentnall T, Bronner M, Byrd D, Haggitt R, Kimmey M . Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 1999; 131(4):247-55. DOI: 10.7326/0003-4819-131-4-199908170-00003. View

13.

Rulyak S, Brentnall T . Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology. 2002; 1(5):477-85. DOI: 10.1159/000055851. View

13.

Overbeek K, Levink I, Koopmann B, Harinck F, Konings I, Ausems M . Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut. 2021; 71(6):1152-1160. PMC: 9120399. DOI: 10.1136/gutjnl-2020-323611. View

14.

Kimmey M, Bronner M, Byrd D, Brentnall T . Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc. 2002; 56(4 Suppl):S82-6. DOI: 10.1016/s0016-5107(02)70092-8. View

15.

Canto M, Goggins M, Yeo C, Griffin C, Axilbund J, Brune K . Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004; 2(7):606-21. DOI: 10.1016/s1542-3565(04)00244-7. View

16.

Canto M, Goggins M, Hruban R, Petersen G, Giardiello F, Yeo C . Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006; 4(6):766-81. DOI: 10.1016/j.cgh.2006.02.005. View

17.

Canto M, Almario J, Schulick R, Yeo C, Klein A, Blackford A . Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology. 2018; 155(3):740-751.e2. PMC: 6120797. DOI: 10.1053/j.gastro.2018.05.035. View

18.

Dbouk M, Katona B, Brand R, Chak A, Syngal S, Farrell J . The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. J Clin Oncol. 2022; 40(28):3257-3266. PMC: 9553376. DOI: 10.1200/JCO.22.00298. View